Coastal Bridge Advisors, LLC Abb Vie Inc. Transaction History

Coastal Bridge Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $187,133 - $224,422	1,353 New	1,353 $218,000
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $23,120 - $29,393	-168 Reduced 10.58%	1,420 $217,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $170,598 - $215,856	1,588 New	1,588 $215,000

3,795

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.